Currently, radiation therapy and the resection of metastatic lesions are the first-line treatments for brain metastasis in HER2-positive breast cancer [9,10], while the chemotherapy and HER2-targeted therapy used for primary tumors are not actively recommended for brain metastasis. This evidence concerns the gene ERBB2 and breast carcinoma.